Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |